Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Anemia and SF3B1[original query] |
|---|
| Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
| Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1. Haematologica 2013 Mar 98 (3): 420-3. Ambaglio Ilaria, Malcovati Luca, Papaemmanuil Elli, Laarakkers Coby M, Della Porta Matteo G, Gallì Anna, Da Vià Matteo C, Bono Elisa, Ubezio Marta, Travaglino Erica, Albertini Riccardo, Campbell Peter J, Swinkels Dorine W, Cazzola Mar |
| SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution. American journal of hematology 2014 Aug 89 (8): E109-15. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Wu Shang-Ju, Liu Chieh-Yu, Chen Chien-Yuan, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Hsu Szu-Chun, Ko Bor-Sheng, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts. PloS one 2015 10 (5): e0126555. del Rey Mónica, Benito Rocío, Fontanillo Celia, Campos-Laborie Francisco J, Janusz Kamila, Velasco-Hernández Talía, Abáigar María, Hernández María, Cuello Rebeca, Borrego Daniel, Martín-Zanca Dionisio, De Las Rivas Javier, Mills Ken I, Hernández-Rivas Jesús |
| SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 2015 Jul 126 (2): 233-41. Malcovati Luca, Karimi Mohsen, Papaemmanuil Elli, Ambaglio Ilaria, Jädersten Martin, Jansson Monika, Elena Chiara, Gallì Anna, Walldin Gunilla, Della Porta Matteo G, Raaschou-Jensen Klas, Travaglino Erica, Kallenbach Klaus, Pietra Daniela, Ljungström Viktor, Conte Simona, Boveri Emanuela, Invernizzi Rosangela, Rosenquist Richard, Campbell Peter J, Cazzola Mario, Hellström Lindberg E |
| A randomized phase II trial of azacitidine +/- epoetin-ß in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents. Haematologica 2016 May . Thépot Sylvain, Ben Abdelali Raouf, Chevret Sylvie, Renneville Aline, Beyne-Rauzy Odile, Prébet Thomas, Park Sophie, Stamatoullas Aspasia, Guerci-Bresler Agnes, Cheze Stéphane, Tertian Gérard, Choufi Bachra, Legros Laurence, Bastié Jean Noel, Delaunay Jacques, Chaury Marie Pierre, Sanhes Laurence, Wattel Eric, Dreyfus Francois, Vey Norbert, Chermat Fatiha, Preudhomme Claude, Fenaux Pierre, Gardin Clau |
| Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. American journal of hematology 2016 Feb . Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS). Leukemia & lymphoma 2016 Oct 1-8. Martín Iván, Such Esperanza, Navarro Blanca, Vicente Ana, López-Pavía María, Ibáñez Mariam, Tormo Mar, Villamón Eva, Gómez-Seguí Inés, Luna Irene, Oltra Silvestre, Pedrola Laia, Sanz Miguel Angel, Cervera Jose, Sanz Guiller |
| Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms. Klinische Padiatrie 2017 11 229 (6): 329-334. Chao Mwe Mwe, Thomay Kathrin, Goehring Gudrun, Wlodarski Marcin, Pastor Victor, Schlegelberger Brigitte, Schindler Detlev, Kratz Christian Peter, Niemeyer Charlot |
| Mutations and karyotype predict treatment response in myelodysplastic syndromes. American journal of hematology 2018 8 93 (11): 1420-1426. Idossa Dame, Lasho Terra L, Finke Christy M, Ketterling Rhett P, Patnaik Mrinal M, Pardanani Animesh, Gangat Naseema, Tefferi Ayal |
| Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget 2018 Jun 9 (45): 27882-27894. Kuendgen Andrea, Müller-Thomas Catharina, Lauseker Michael, Haferlach Torsten, Urbaniak Petra, Schroeder Thomas, Brings Carolin, Wulfert Michael, Meggendorfer Manja, Hildebrandt Barbara, Betz Beate, Royer-Pokora Brigitte, Gattermann Norbert, Haas Rainer, Germing Ulrich, Götze Katharina |
| Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology. International journal of laboratory hematology 2018 10 41 (1): 109-117. Bastida José María, López-Godino Oriana, Vicente-Sánchez Ana, Bonanad-Boix Santiago, Xicoy-Cirici Blanca, Hernández-Sánchez Jesus M, Such Esperanza, Cervera Jose, Caballero-Berrocal Juan C, López-Cadenas Félix, Arnao-Herráiz Mario, Rodríguez Inés, Llopis-Calatayud Inmaculada, Jiménez María J, Del Cañizo-Roldán Maria Consuelo, Díez-Campelo Mar |
| Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes. International journal of hematology 2018 Dec 108 (6): 598-606. Shingai Naoki, Harada Yuka, Iizuka Hiroko, Ogata Yosuke, Doki Noriko, Ohashi Kazuteru, Hagihara Masao, Komatsu Norio, Harada Hirono |
| The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia. American journal of hematology 2019 Jul . Zheng Gang, Chen Ping, Pallavajjalla Aparna, Haley Lisa, Gondek Lukasz, Dezern Amy, Ling Hua, De Marchi Federico, Lin Ming-Tseh, Gocke Christoph |
| TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia 2019 Jan . Haase Detlef, Stevenson Kristen E, Neuberg Donna, Maciejewski Jaroslaw P, Nazha Aziz, Sekeres Mikkael A, Ebert Benjamin L, Garcia-Manero Guillermo, Haferlach Claudia, Haferlach Torsten, Kern Wolfgang, Ogawa Seishi, Nagata Yasunobu, Yoshida Kenichi, Graubert Timothy A, Walter Matthew J, List Alan F, Komrokji Rami S, Padron Eric, Sallman David, Papaemmanuil Elli, Campbell Peter J, Savona Michael R, Seegmiller Adam, Adès Lionel, Fenaux Pierre, Shih Lee-Yung, Bowen David, Groves Michael J, Tauro Sudhir, Fontenay Michaela, Kosmider Olivier, Bar-Natan Michal, Steensma David, Stone Richard, Heuser Michael, Thol Felicitas, Cazzola Mario, Malcovati Luca, Karsan Aly, Ganster Christina, Hellström-Lindberg Eva, Boultwood Jacqueline, Pellagatti Andrea, Santini Valeria, Quek Lynn, Vyas Paresh, Tüchler Heinz, Greenberg Peter L, Bejar Rafael, |
| Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals. Blood 2020 4 135 (14): 1161-1170. van Zeventer Isabelle A, de Graaf Aniek O, Wouters Hanneke J C M, van der Reijden Bert A, van der Klauw Melanie M, de Witte Theo, Jonker Marianne A, Malcovati Luca, Jansen Joop H, Huls Gerw |
| Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis. Haematologica 2021 9 107 (8): 1815-1826. Gutierrez-Rodrigues Fernanda, Beerman Isabel, Groarke Emma M, Patel Bhavisha A, Spitofsky Nina, Dillon Laura W, Raffo Diego Quinones, Hourigan Christopher S, Kajigaya Sachiko, Ferrucci Luigi, Young Neal |
| ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International journal of hematology 2022 7 116 (5): 659-668. Morita Yasuyoshi, Nannya Yasuhito, Ichikawa Motoshi, Hanamoto Hitoshi, Shibayama Hirohiko, Maeda Yoshinobu, Hata Tomoko, Miyamoto Toshihiro, Kawabata Hiroshi, Takeuchi Kazuto, Tanaka Hiroko, Kishimoto Junji, Miyano Satoru, Matsumura Itaru, Ogawa Seishi, Akashi Koichi, Kanakura Yuzuru, Mitani Kinu |
| Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Blood cancer journal 2022 2 12 (2): 26. Mangaonkar Abhishek A, Lasho Terra L, Ketterling Rhett P, Reichard Kaaren K, Gangat Naseema, Al-Kali Aref, Begna Kebede H, Pardanani Animesh, Al Ali Najla H, Talati Chetasi, Sallman David, Padron Eric, Patnaik Mrinal M, Tefferi Ayalew, Komrokji Ra |
| STEREOTYPED CASES IN UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS DEPENDING ON THE IONIZING RADIATION EXPOSURE. Problemy radiatsiinoi medytsyny ta radiobiolohii 2022 12 27 307-323. Bilous N I, Abramenko I V, Chumak A A, Dyagil I S, Martina Z |
| The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts. Research square 2023 4 . In Young Choi, Jonathan Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Riley Bergman, Céline Philippe, James Manley, Kevin Rouault-Pierre, Bing Li, Daniel Wiseman, Madhu Ouseph, Elsa Bernard, Xiao Li, Torsten Haferlach, Salman Fazal, Tania Jain, Christopher Gocke, Amy DeZern, W Brian Dalt |
| Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 2023 10 . Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Uta Oelschlägel, Wolfgang E Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D Baldus, Andreas Dahl, Johannes Schetelig, Martin Bornhäuser, Jan Moritz Middeke, Christian Thie |
| [Genetic Variation of SH2B3 in Patients with Myeloid Neoplasms]. Zhongguo shi yan xue ye xue za zhi 2024 8 32 (4): 1186-1190. Qiang Ma, Rong-Hua Hu, Hong Zhao, Xiao-Xi Lan, Yi-Xian Guo, Xiao-Li Chang, Wan-Ling Sun, Li Su, Wu-Han H |
- Page last reviewed:Feb 1, 2024
- Content source: